Jonsson Comprehensive Cancer Center
Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2007-01-29
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00427427
- Locations
- 🇺🇸
Revlon/UCLA Breast Center, Los Angeles, California, United States
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
- Conditions
- Ocular MelanomaChoroidal MelanomaUveal Melanoma
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 174
- Registration Number
- NCT00351728
- Locations
- 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
- Conditions
- Ocular Melanoma
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2019-08-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT00346372
- Locations
- 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 19
- Registration Number
- NCT00345826
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Cytogenetic Study of Ocular Melanoma
- Conditions
- Choroidal Melanoma
- First Posted Date
- 2006-06-27
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 95
- Registration Number
- NCT00344799
- Locations
- 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
- Conditions
- Leukemia
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT00335868
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
- Conditions
- Sarcoma
- Interventions
- Procedure: positron emission tomography computed tomography (PET/CT)
- First Posted Date
- 2006-06-12
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 120
- Registration Number
- NCT00335751
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
- Conditions
- Lung CancerLymphomaLymphoproliferative DisorderUnspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00324597
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
- Conditions
- Kidney Cancer
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 65
- Registration Number
- NCT00301990
- Locations
- 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00278187
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States